Vincere Biosciences

Developing the therapy for Parkinson's disease

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 groups7 employees language vincerebio.com

Innovation

2 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 135 times.

YearFilings
20211
20222
20232
20242
20251

Social engagement

Social engagement: 4.3K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Daewoong, Hanall Biopharma.

Investor typeCountShare
Venture capital333%
Accelerator & incubator111%
Other / undisclosed556%

Recent activity

23 Jun 2026
Event
Clinical Trials for Parkinson's disease webinar
22 Jun 2026
Event
extracellular vesicles webinar hosted by Spring Behrouz
Coming soon